Impact of staphylococcal protease expression on the outcome of infectious arthritis

Microbes and Infection

Volumn 6, Issue 2, 2004, Pages 202-206

  Calander, Ann Marie ^a   Jonsson, Ing Marie ^a   Kanth, Anna ^b   Arvidsson, Staffan ^b   Shaw, Lindsey ^c   Foster, Simon J ^c   Tarkowski, Andrej ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Aureolysin; Bacterial protease; Cysteine protease; Exoprotease; Septic arthritis; Serine protease; Staphylococcus aureus; Virulence

Indexed keywords

AUREOLYSIN; CYSTEINE PROTEINASE; EXOPEPTIDASE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL STRAIN; BACTERIUM MUTANT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE INACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; WILD TYPE;

ANIMALS; ARTHRITIS, INFECTIOUS; CYSTEINE ENDOPEPTIDASES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, BACTERIAL; MICE; SERINE ENDOPEPTIDASES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 1442348326     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2003.10.015     Document Type: Article

References (19)

1. Shopsin B., Mathema B., Martinez J., Ha E., Campo M.L., Fierman A., Krasinski K., Kornblum J., Alcabes P., Waddington M., Riehman M., Kreiswirth B.N. Prevalence of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in the community. J. Infect. Dis. 182:2000;359-362.
2. Zanelli G., Sansoni A., Zanchi A., Cresti S., Pollini S., Rossolini G.M., Cellesi S. Staphylococcus aureus nasal carriage in the community: a survey from central Italy. Epidemiol. Infect. 129:2002;417-420.
3. Eady E.A., Cove J.H. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections. Curr. Opin. Infect. Dis. 16:2003;103-124.
4. Hoban D.J., Biedenbach D.J., Mutnick A.H., Jones R.N. Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000). Diagn. Microbiol. Infect. Dis. 45:2003;279-285.
5. Petti C.A., Fowler V.G. Jr. Staphylococcus aureus bacteremia and endocarditis. Infect. Dis. Clin. North Am. 16:2002;413-435. x-xi.
6. Dubost J.J., Soubrier M., Sauvezie B. Pyogenic arthritis in adults. Joint Bone Spine. 67:2000;11-21.
7. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., Cohen J., Opal S.M., Vincent J.L., Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 29:2003;530-538.
8. Tumbarello M., de Gaetano Donati K., Tacconelli E., Citton R., Spanu T., Leone F., Fadda G., Cauda R. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J. Antimicrob. Chemother. 50:2002;375-382.
9. Nolla J.M., Gomez-Vaquero C., Fiter J., Mateo L., Juanola X., Rodriguez-Moreno J., Valverde J., Roig-Escofet D. Pyarthrosis in patients with rheumatoid arthritis: a detailed analysis of 10 cases and literature review. Semin. Arthr. Rheum. 30:2000;121-126.
10. Tarkowski A., Bokarewa M., Collins L.V., Gjertsson I., Hultgren O.H., Jin T., Jonsson I.M., Josefsson E., Sakiniene E., Verdrengh M. Current status of pathogenetic mechanisms in staphylococcal arthritis. FEMS Microbiol. Lett. 217:2002;125-132.
11. Potempa J., Fedak D., Dubin A., Mast A., Travis J. Proteolytic inactivation of alpha-1-anti-chymotrypsin. Sites of cleavage and generation of chemotactic activity. J. Biol. Chem. 266:1991;21482-21487.
12. Potempa J., Watorek W., Travis J. The inactivation of human plasma alpha 1-proteinase inhibitor by proteinases from Staphylococcus aureus. J. Biol. Chem. 261:1986;14330-14334.
13. Prokesova L., Potuznikova B., Potempa J., Zikan J., Radl J., Porwit-Bobr Z., John C. Cleavage of human immunoglobulins by proteinase from Staphylococcus aureus. Adv. Exp. Med. Biol. 371A:1995;613-616.
14. Potempa J., Dubin A., Korzus G., Travis J. Degradation of elastin by a cysteine proteinase from Staphylococcus aureus. J. Biol. Chem. 263:1988;2664-2667.
15. Drapeau G.R. Role of metalloprotease in activation of the precursor of staphylococcal protease. J. Bacteriol. 136:1978;607-613.
16. Karlsson A., Arvidson S. Variation in extracellular protease production among clinical isolates of Staphylococcus aureus due to different levels of expression of the protease repressor sarA. Infect. Immun. 70:2002;4239-4246.
17. Karlsson A., Saravia-Otten P., Tegmark K., Morfeldt E., Arvidsson S. Decreased amounts of cell wall-associated protein A and fibronectin-binding proteins in Staphylococcus aureus sarA mutants due to up-regulation of extracellular proteases. Infect. Immun. 69:2001;4742-4748.
18. Bremell T., Lange S., Yacoub A., Ryden C., Tarkowski A. Experimental Staphylococcus aureus arthritis in mice. Infect. Immun. 59:1991;2615-2623.
19. McAleese F.M., Walsh E.J., Sieprawska M., Potempa J., Foster T.J. Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease. J. Biol. Chem. 276:2001;29969-29978.